Hereditary Breast Cancer & Genetic Testing Webinar

Some breast cancers are thought to be hereditary, caused by abnormal genes passed from parent to child. Most cases of hereditary breast cancer are associated with inherited mutations in two genes: BRCA1 (BReast CAncer gene one) and BRCA2 (BReast CAncer gene two). Together BRCA1 and BRCA2 mutations account for about 25 to 30 percent of hereditary breast cancers, and approximately three to six percent of all breast cancers.

While all patients with metastatic breast cancer (MBC) face a complex and difficult journey, those whose disease can be attributed to inherited gene mutations could face unique challenges. These can include, but are not limited to, lack of access to support services, or genetic counseling. Importantly, it also can include the weight of knowing that others in their family may be at risk.

Join us for a webinar with Dr. Lily Shahied Arruda, Medical Director, U.S. Medical Affairs at Pfizer Oncology, when we will learn more about breast cancer patients’ experiences and knowledge of hereditary breast cancer and genetic testing.

Genomics: How DNA Can Inform Cancer Diagnosis & Treatment

The National Cancer Institute (NCI) will hold a Facebook Live event that will feature NCI subject matter experts Kenneth Aldape, M.D., of the Center for Cancer Research, Megan Frone, M.S., C.G.C., of the Division of Cancer Epidemiology and Genetics, and Lyndsay Harris, M.D., of the Cancer Diagnosis Program. They will discuss the role of genetics in cancer diagnosis and treatment. Participants are encouraged to ask questions to our experts during the event in the comments section.

View the event live on the NCI Facebook page.

Genomics and Genetics: What is the Difference?

Topics Covered

  • Definition of Genetics & Genomics
  • The Importance of Genetic & Genomic Testing
  • The Value of Early Testing to Inform Your Treatment Choices
  • Their Role in Selecting Your Cancer Treatment
  • Understanding Types of Gene Mutations
  • The Difference Between Inherited & Acquired or Sporadic Gene Mutations
  • The Role of the Pathologist
  • How Genomic Testing Drives Your Cancer Treatment
  • Current Research in Genomics
  • Genomic Profiling May Identify Actionable Alterations
  • Examples of How Genomics Identify Your State-of-the-Art Treatment
  • Key Questions to Ask Your Health Care Team about Genetic and Genomic Testing
  • Questions for Our Panel of Experts

Considering BRCA Genes: Knowledge Improves Outcomes

We are honored to gather critical members of the team who are changing the BRCA landscape in the Bay Area and beyond. We invite you to join University of California San Franciso’s global health experts Heather Greenwood, MD; Alan Ashworth, PhD, FRS; Pamela Munster, MD; and Mindy Goldman, MD; breast cancer survivor and patient advocate Laura Holmes Haddad, author of This is Cancer: Everything You Need to Know, From the Waiting Room to the Bedroom; as well as our MC for the evening, Larisa Kure, breast cancer survivor and associate dean of administration and finance of the School of Denstistry, for refreshments and conversation. Whether you know your BRCA status or need to learn more, this gathering will help you understand genetic risks and how they affect health outcomes.

Up ↑